Sabine Ponader

1.5k total citations · 1 hit paper
24 papers, 1.2k citations indexed

About

Sabine Ponader is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Sabine Ponader has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 9 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Sabine Ponader's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Bone Tissue Engineering Materials (6 papers). Sabine Ponader is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Bone Tissue Engineering Materials (6 papers). Sabine Ponader collaborates with scholars based in Germany, United States and Greece. Sabine Ponader's co-authors include Jan A. Burger, Michael J. Keating, William G. Wierda, Joseph J. Buggy, Kumudha Balakrishnan, Varsha Gandhi, Susan O’Brien, Shih-Shih Chen, Nicholas Chiorazzi and Friedrich Wilhelm Neukam and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sabine Ponader

24 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo

2011 499 citations Sabine Ponader, Shih-Shih Chen et al. Blood profile →

Peers

Countries citing papers authored by Sabine Ponader

Since Specialization

Citations

This map shows the geographic impact of Sabine Ponader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Ponader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Ponader more than expected).

Fields of papers citing papers by Sabine Ponader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Ponader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Ponader. The network helps show where Sabine Ponader may publish in the future.

Co-authorship network of co-authors of Sabine Ponader

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Ponader. A scholar is included among the top collaborators of Sabine Ponader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Ponader. Sabine Ponader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evidence of Inbreeding in Hodgkin Lymphoma 2016 ·PLoS ONE ·Hauke Thomsen, Miguel Inácio da Silva Filho, Michael Fuchs, Sabine Ponader, Elke Pogge von Strandmann, Lewin Eisele, Stefan Herms, Per Hoffmann, Andreas Engert, Kari Hemminki, Asta Försti	7
2	Heritability estimates on Hodgkin’s lymphoma: a genomic- versus population-based approach 2014 ·European Journal of Human Genetics ·Hauke Thomsen, Miguel Inácio da Silva Filho, Asta Försti, Michael Fuchs, Sabine Ponader, Elke Pogge von Strandmann, Lewin Eisele, Stefan Herms, P. Hofmann, Jan Sundquist, Andreas Engert, Kari Hemminki	5
3	Bruton's Tyrosine Kinase: From X-Linked Agammaglobulinemia Toward Targeted Therapy for B-Cell Malignancies 2014 ·Journal of Clinical Oncology ·Sabine Ponader, Jan A. Burger	87
4	The Chemokine CCL17/TARC as a Biomarker in Hodgkin Lymphoma 2013 ·Maike Sauer, Sabine Ponader, Andreas Engert, Elke Pogge von Strandmann	1
5	Target Engagement, Pathway Inhibition, and Efficacy Of The Bruton’s Tyrosine Kinase (Btk) Inhibitor CC-292 2013 ·Blood ·Daniel W. Pierce, Sabine Ponader, Kumudha Balakrishnan, Varsha Gandhi, William G. Wierda, Susan O’Brien, Carla Heise, Mariana Nacht, (unknown), Xiping Liu, (unknown), Shijuan Wu, Marianna Zavodovskaya, (unknown), (unknown), Pilar Nava-Parada, Jay Mei, Rajesh Chopra, Jan A. Burger, Juswinder Singh	1
6	Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma 2013 ·Blood ·Jing Ouyang, Annette Plütschow, Elke Pogge von Strandmann, Katrin S. Reiners, Sabine Ponader, Gabriel A. Rabinovich, Donna Neuberg, Andreas Engert, Margaret A. Shipp	65
7	Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma 2012 ·American Journal of Hematology ·Maike Sauer, Annette Plütschow, Ron D. Jachimowicz, (unknown), Katrin S. Reiners, Sabine Ponader, Andreas Engert, Elke Pogge von Strandmann	56
8	Galectin-1 Serum Levels Reflect Tumor Burden and Adverse Clinical Features in Hodgkin Lymphoma 2012 ·Blood ·Jing Ouyang, Annette Plütschow, (unknown), Sabine Ponader, Gabriel A. Rabinovich, Donna Neuberg, Andreas Engert, Margaret A. Shipp	1
9	Clinical Development of AVL-292; A Potent, Selective Covalent Btk Inhibitor for the Treatment of B Cell Malignancies, 2011 ·Blood ·Erica N Evans, Richland Tester, (unknown), Prasoon Chaturvedi, Hormoz Mazdiyasni, Sabine Ponader, Bethany Tesar, Michael P. Sheets, Mariana Nacht, (unknown), (unknown), Heather Lounsbury, Russell C. Petter, Jennifer R. Brown, Jan A. Burger, Juswinder Singh, William Westlin	19
10	The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo breakdown → 2011 ·Blood ·Sabine Ponader, Shih-Shih Chen, Joseph J. Buggy, Kumudha Balakrishnan, Varsha Gandhi, William G. Wierda, Michael J. Keating, Susan O’Brien, Nicholas Chiorazzi, Jan A. Burger	499
11	Analysis of rainbow troutOncorhynchus mykissepidermal mucus and evaluation of semiochemical activity for polar filament discharge inMyxobolus cerebralisactinospores 2010 ·Journal of Fish Biology ·(unknown), Sabine Ponader, (unknown), (unknown), Rudolf Geyer, Wilfried Haas, Mansour El‐Matbouli	8
12	Microenvironment Influences Expression of TOSO – a Novel NF-Kappa B Target Gene In Chronic Lymphocytic Leukemia 2010 ·Blood ·Lukas P. Frenzel, Alexandra Schulz, Christian P. Pallasch, Rainer Claus, Sabine Ponader, Jan A. Burger, Michael Hallek, Christoph Plass, Clemens‐Martin Wendtner	1
13	Bruton's Tyrosine Kinase Inhibitor PCI-32765 Abrogates BCR- and Nurselike Cell-Derived Activation of CLL Cells In Vitro and In Vivo. 2010 ·Blood ·Sabine Ponader, Joseph J. Buggy, Susan O’Brien, William G. Wierda, Michael J. Keating, Jan A. Burger	3
14	A novel Multiple-Marker Method for the Early Diagnosis of Oral Squamous Cell Carcinoma 2009 ·SHILAP Revista de lepidopterología ·Jutta Ries, Nur Mollaoğlu, Takeshi Toyoshima, Eleftherios Vairaktaris, Friedrich Wilhelm Neukam, Sabine Ponader, Emeka Nkenke	16
15	In vitro behavior of layer-by-layer deposited molecular oligoelectrolyte films on Ti–6Al–4V surfaces 2009 ·Journal of Materials Science Materials in Medicine ·Sabine Ponader, (unknown), Eleftherios Vairaktaris, Cornelius von Wilmowsky, (unknown), Friedrich Wilhelm Neukam, Cordula D. Schmidt, (unknown), Andreas Hirsch, Emeka Nkenke	5
16	In vivo performance of selective electron beam‐melted Ti‐6Al‐4V structures 2009 ·Journal of Biomedical Materials Research Part A ·Sabine Ponader, Cornelius von Wilmowsky, (unknown), Rainer Lutz, Peter Heinl, Carolin Körner, Robert F. Singer, Emeka Nkenke, Friedrich Wilhelm Neukam, Karl Andreas Schlegel	146
17	In vitro response of hFOB cells to pamidronate modified sodium silicate coated cellulose scaffolds 2008 ·Colloids and Surfaces B Biointerfaces ·Sabine Ponader, (unknown), Eleftherios Vairaktaris, Cornelius von Wilmowsky, Emeka Nkenke, (unknown), Friedrich Wilhelm Neukam, Stefan Holst, Frank A. Müller, Peter Greil	20
18	Myxozoan transmission via actinospores: new insights into mechanisms and adaptations for host invasion 2007 ·Parasitology ·(unknown), Sabine Ponader, Edit Eszterbauer, Mansour El‐Matbouli, Wilfried Haas	27
19	Effects of topographical surface modifications of electron beam melted Ti‐6Al‐4V titanium on human fetal osteoblasts 2007 ·Journal of Biomedical Materials Research Part A ·Sabine Ponader, Eleftherios Vairaktaris, Peter Heinl, Cornelius von Wilmowsky, (unknown), Carolin Körner, Robert F. Singer, Stefan Holst, Karl Andreas Schlegel, Friedrich Wilhelm Neukam, Emeka Nkenke	132
20	Processing of Three‐Dimensional Laser Sintered Polyetheretherketone Composites and Testing of Osteoblast Proliferation in vitro 2007 ·Macromolecular Symposia ·Dirk Pohle, Sabine Ponader, Thomas Rechtenwald, Michael Schmidt, Karl Andreas Schlegel, Helmut Münstedt, Friedrich Wilhelm Neukam, Emeka Nkenke, Cornelius von Wilmowsky	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact